Skip to main content
. Author manuscript; available in PMC: 2011 Jan 6.
Published in final edited form as: Mol Cancer Ther. 2010 Jan 6;9(1):1. doi: 10.1158/1535-7163.MCT-09-0321

Table 1.

E-cadherin methylation, transcript, protein, and DNA copy number, and six E-cad transcriptional repressor transcript profiles.

E-cadherin profiles

Mean Transcript levels Protein E-cad transcriptional repressors transcript levels a


Cell line b methylation c Hu6800d 9706 cDNA e U95 f U133 g levels h aCGH i SNAl1 j,k SNal2 l,k TCF3 m,k TCF8 n,k TWIST1 o ZFHX1B p





BR:BT-549 54 4.91 0.51 4.32 4.82 −1.46 −0.15 5.75 7.09 6.28 7.59 6.82 3.68
BR:HS578T 47 4.58 0.47 4.32 4.91 −0.69 NAp 5.59 10.11 5.95 8.32 6.27 4.42
BR:MCF7 21 9.39 2.82 9.01 8.39 1.63 0.11 5.74 4.38 6.35 3.63 3.84 3.02
BR:MDA-MB-231 13 4.32 0.21 4.32 4.87 −2.62 −0.37 5.41 8.16 5.91 7.42 3.49 3.32
BR:T47D 6 8.96 2.96 9.44 8.46 1.66 −0.04 5.48 4.22 6.22 3.63 3.86 3.09





CNS:SF-268 48 4.70 0.40 4.32 4.56 −2.06 −0.26 5.36 6.98 5.86 7.04 6.15 5.11
CNS:SF-295 43 4.32 0.66 4.32 4.99 −1.37 0.33 6.33 7.32 5.89 7.18 6.30 3.37
CNS:SF-539 73 4.32 0.75 4.32 4.85 −1.73 −0.13 6.61 9.91 5.97 7.42 5.78 4.06
CNS:SNB19 86 5.17 0.46 4.30 4.92 −1.16 0.40 5.64 6.00 6.18 6.22 6.26 3.49
CNS:SNB-75 16 4.39 0.62 4.32 4.81 −1.92 −0.03 6.57 7.94 6.37 7.01 5.65 4.93
CNS:U251 93 5.29 0.39 4.30 4.83 −1.74 −0.10 5.51 6.39 5.98 5.61 5.43 3.84





CO:COLO205 8 9.52 2.34 9.50 7.77 1.08 −0.14 5.97 4.26 6.11 3.81 3.74 3.09
CO:HCC-2998 11 7.81 1.46 8.58 6.13 1.56 0.33 5.98 4.37 6.50 3.65 4.02 2.98
CO:HCT-116 9 6.29 0.60 5.90 4.97 −0.16 0.03 6.19 4.44 6.42 4.52 4.16 3.12
CO:HCT-15 11 8.08 2.22 8.99 6.47 1.10 0.01 5.65 4.21 6.30 3.57 3.66 3.17
CO:HT29 8 5.75 1.53 8.50 6.05 1.51 −0.01 5.72 4.36 6.26 3.70 3.64 3.19
CO:KM12 6 7.55 1.27 8.04 6.33 0.32 0.03 5.83 4.56 6.36 4.17 3.72 3.09
CO:SW-620 graphic file with name nihms161850t1.jpg 6.75 0.80 7.02 5.20 0.07 0.12 6.17 4.97 6.18 5.18 3.61 3.12





LC:A549-ATCC 14 6.89 0.88 6.90 5.12 −0.52 0.15 5.98 4.38 6.58 5.77 3.99 3.13
LC:EKVX 7 7.72 1.13 6.90 5.58 −0.03 0.33 5.93 4.50 6.34 6.05 3.72 3.08
LC:HOP-62 21 4.32 0.41 4.32 4.88 −1.40 −0.15 6.14 5.35 6.14 6.14 5.79 3.50
LC:HOP-92 7 4.32 0.30 4.32 4.71 −1.76 0.21 5.89 7.75 6.57 6.95 3.99 3.12
LC:NCI-H226 12 6.11 0.46 4.30 4.86 −1.44 0.00 5.69 7.32 6.14 6.37 5.55 3.74
LC:NCI-H23 12 44.6 0.27 4.30 4.69 −2.31 0.11 5.61 5.20 5.93 6.67 5.85 3.59
LC:NCI-H322M 9 8.08 2.36 9.25 6.63 1.80 NA p 5.55 4.84 6.16 3.51 4.36 3.07
LC:NCI-H460 41 4.32 0.58 4.30 4.90 −0.55 0.46 6.09 4.95 6.50 5.66 3.64 3.42
LC:NCI-H522 15 4.46 0.34 4.32 4.94 −1.17 NA p 6.07 4.32 6.24 6.74 5.09 3.17





LE:CCRF-CEM 88 4.75 0.39 4.32 4.99 −2.58 0.22 5.62 4.39 6.39 8.17 4.08 3.19
LE:HL-60 85 4.46 0.35 4.32 5.24 −2.59 0.44 6.07 4.29 6.50 6.12 4.37 4.43
LE:K-562 98 5.83 0.36 4.32 4.97 −3.29 0.06 6.15 4.32 6.06 4.73 3.80 5.19
LE:MOLT-4 97 4.32 0.47 4.32 5.03 −2.13 0.00 5.61 4.48 6.36 7.42 3.97 3.16
LE:RPMI-8226 39 5.39 0.84 4.32 5.06 −1.48 0.40 5.94 5.62 6.38 5.34 3.69 3.15
LE:SR 95 4.32 0.36 4.32 4.84 −1.51 −0.02 5.41 4.73 6.03 6.43 5.54 4.35





ME:LOXIMVI 85 4.32 0.52 4.32 4.79 −1.64 −0.17 5.66 9.98 6.11 7.54 5.06 4.00
ME:M14 20 4.32 0.69 4.32 5.03 −2.52 −0.05 5.74 8.90 6.22 3.72 5.97 4.93
ME:MALME-3M 12 7.28 1.00 9.04 6.23 −0.28 −0.44 5.81 8.14 6.32 3.88 4.48 4.78
ME:MDA-MB-435 r 84 4.32 0.33 4.32 5.14 −1.44 −0.42 5.95 9.57 6.16 5.08 5.70 4.60
ME:MDA-N r 84 4.32 0.35 4.32 4.80 −1.49 −0.46 5.73 9.65 5.92 5.71 6.03 5.69
ME:SK-MEL-2 graphic file with name nihms161850t2.jpg 4.32 0.40 4.32 5.11 −1.74 −0.03 6.06 6.46 6.57 4.44 6.32 4.09
ME:SK-MEL-28 5.25 0.33 4.32 4.76 −2.37 −0.47 5.51 9.86 5.96 4.07 5.71 5.85
ME:SK-MEL-5 80 6.89 0.58 5.13 5.23 −2.13 −0.23 5.81 8.90 6.43 4.36 5.64 4.31
ME:UACC-257 7 7.34 1.17 7.48 5.58 −0.64 −0.04 5.76 10.00 6.29 3.52 4.70 5.07
ME:UACC-62 59 4.32 0.45 4.32 4.98 −3.05 −0.29 6.47 8.55 6.44 5.36 5.74 4.10





OV:IGROV1 graphic file with name nihms161850t3.jpg 4.95 0.61 4.32 4.93 −1.97 0.03 5.86 4.49 6.61 5.87 3.60 3.06
OV:OVCAR-3 8 7.20 0.99 6.83 5.47 −1.70 −0.60 6.23 4.42 6.28 3.85 4.98 3.06
OV:OVCAR-4 5 7.22 1.20 7.43 5.56 1.80 −0.48 6.19 4.27 6.48 3.75 5.09 3.19
OV:OVCAR-5 13 5.70 0.41 4.32 4.81 −1.91 −0.20 5.69 5.42 6.37 6.40 3.67 3.29
OV:OVCAR-8 85 5.21 0.32 4.32 4.82 −1.78 0.22 5.81 4.97 6.18 6.53 3.69 3.57
OV:OVCAR8/ADR-RES s 89 6.19 0.32 4.32 4.96 −2.03 0.24 6.14 5.95 6.24 5.29 5.77 3.46
OV:SKOV3−3 8 5.36 0.72 4.32 5.32 −0.92 0.15 5.86 5.95 6.46 5.50 5.09 3.13





PR:DU-145 14 6.74 0.47 5.58 5.19 −0.16 0.04 5.98 4.60 6.34 5.41 3.73 3.22
PR:PC-3 15 6.75 0.69 4.83 5.21 −2.18 −0.07 5.89 7.23 6.52 5.48 5.67 3.33





RE:786-0 87 4.58 0.44 4.32 4.69 −1.87 0.10 6.25 6.57 6.18 5.97 3.58 3.40
RE:A498 93 4.46 0.53 4.32 4.61 −1.61 0.34 6.49 4.73 6.43 5.50 3.64 3.52
RE:ACHN 10 5.81 0.58 5.51 5.01 −2.16 0.35 5.61 4.73 6.20 5.76 3.56 3.70
RE:CAKI-1 33 6.74 0.78 4.64 4.97 −2.30 0.66 6.27 4.48 6.34 5.81 5.10 3.36
RE:RXF-393 graphic file with name nihms161850t4.jpg 4.32 0.33 4.32 4.73 −1.62 −0.14 6.06 7.00 6.12 7.04 3.50 4.61
RE:SN12C 74 5.55 0.29 4.32 4.96 −1.25 0.72 5.76 5.42 6.43 7.03 5.58 3.39
RE:TK-10 99 4.32 0.27 4.32 5.02 −2.25 −0.03 6.25 5.41 6.52 4.68 3.83 3.30
RE:UO-31 12 5.78 0.43 4.32 4.07 −1.73 0.29 5.86 5.16 6.19 5.95 4.68 3.46
a

U133 transcript measurement, log2-transformed. Data processed using the RMA algorithm. Gray blocks indicate levels of transcriptional associated with low levels of E-cad expression (see Figure 1).

b

Tissues of origin are breast (BR), central nervous system (CNS), colon (CO), non-small cell lung cancer (LC). leukemia (LE), melanoma (ME), ovarian (OV), prostate (PR). and renal (RE).

c

Mean methylation profile of E-cad promoter. The gray and cross hatched blocks are above or within the 20–30% E-cad expression threshold. respectively.

d

Gene accession number Z35402. Hu6800 oligonucleotide arrays.

e

Clone ID 416386. cDNA microarrays. Values are ratios from co-hybridization of an individual cell type and a 12-cell line pool.

f

Fragment name 977_s_at. Affymetrix HG-U95 oligonucleotide microarray, log2-transformed.

g

Affymetrix fragment identifier 201130_s_at.

h

Protein levels expressed as log2 of relative protein concentration from reverse phase protein lysate microarrays.

i

Ploidy-relative DNA content. Values are log2-transformed. Array spot number 1485. BAG number RMC16P004.

j

Common name Snail, Affymetrix identifier 219480_at. Exemplar Sequence Accession Number NM_005985. Data

k

Transcriptional repressors chosen as being representative from multiple probe sets.

l

Common name SLUG. Affymetrix identifier 213139_at, Exemplar Sequence Accession Number AI572079.

m

Common name E12/E47 gene product, Affymetrix identifier 216647_at, Exemplar Sequence Accession Number AL117663. HG-U133 transcript measurements, log2-transformed.

n

Common name ZEB1, Affymetrix identifier 212764 at, Exemplar Sequence Accession Number AI806174.

o

Common name ACS3, Affymetrix identifier 213943_at, Exemplar Sequence Accession Number NM_000474.

p

Common name ZEB2, Affymetrix identifier 203603_s_at, Exemplar Sequence Accession Number NM_014795

q

Data not available.

r

Cell lines considered to be melanomas. See Results section.

s

Cell line considered to be a doxorubirin-selected, resistant derivative of OVCAR-8. Previously named MCF7/ADR-RES and NCI/ADR-RES. See results section.